MEETING AGENDA
11:45 am - lunch available in OHSU’s Rood Family Pavilion
12:00-12:45 pm - SPECTRUM: A Tremfya study in patients with low-BSA,* moderate plaque psoriasis and high-impact site involvement - Jason Hawkes, MD
12:45-1:00 pm - Oregon Dermatology Society Business Meeting
1:00-1:15 pm - Clinical Trials Updates
1:15-1:25 pm - Networking Break
1:25-1:55 pm - Lectures by Frontier Dermatology & OHSU Dermatology Residency Programs (CME)
1:55-2:55 pm - Resident-focused lecture with Jeff North, MD: Update on diagnosing inflammatory skin disease (CME)
2:55-3:25 pm - Patient Case Discussions (CME)
3:25-3:30 pm - Networking Break
3:30-4:00 pm - Lectures by Frontier Dermatology & OHSU Dermatology Residency Programs (CME)
4:00-5:00 pm - Keynote Lecture with Jeff North, MD: Navigating the expanding field of melanocytic tumor types and the diagnostic tools used to assess them (CME)
5:00-6:00 pm - Reception at Frank's Wine Bar (open to all attendees)
FEATURED SPEAKER:
Jeff North, MD
Professor of Pathology & Dermatology
Managing Director of Dermatopathology
University of California San Francisco
After finishing undergraduate studies in molecular biology and chemistry at Brigham Young University, I attended medical school at UCSF from 2002-2006. As a first year medical student I began working on melanoma genetics with Boris Bastian, M.D. studying the evolution of melanoma on acral (hands/feet) skin. My interest in dermatology grew during my time at UCSF, leading to a dermatology residency at Oregon Health & Science University, where I served as chief resident from 2009-2010. I returned to UCSF for Dermatopathology fellowship in 2010, followed by a year on faculty as a clinical instructor. After one year on faculty at the University of Missouri as the director of dermatopathology, I rejoined the faculty on the UCSF Dermatopathology and Oral Pathology Service and am delighted to be a member of such an outstanding academic and clinical dermatology and dermatopathology unit.
My interests include increasing diagnostic precision in both inflammatory and neoplastic dermatologic conditions. This includes utilizing molecular techniques such as fluorescent in situ hybridization (FISH) and comparative genomic hybridization (CGH) to better characterize histopathologically ambiguous melanocytic tumors and provide better prognostic information for patients based on cancer-related changes in the tumor genome. I am also interested in immunoprofiling inflammatory skin diseases to allow for more precise diagnosis and understanding of these diseases. In addition, I enjoy teaching and mentoring students, residents and fellows rotating through our service.
VIRTUAL MEETING LINK
https://ohsu.webex.com/ohsu/j.php?MTID=mbe178b3eb65ffecef9ba532763f4b788
Password: MORPHOLOGY (Password needed for non-OHSU guests)
Join by phone:
+1-503-388-9555
Access code: 120 027 8781
CME
Accreditation: this activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of OHSU School of Medicine and Oregon Dermatology Society. The OHSU School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit: OHSU School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Information: office@oregondermatology.org
